Discover our top-rated, regulated brokers. Compare platforms, fees and features, and explore the latest broker offers.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
61% of retail CFD accounts lose money. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more at https://etoro.tw/44JRWLY
CFDs and FX are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
AskTraders may earn a commission when you click through to a broker.
Shares of AstraZeneca plc (LON: AZN) today fell 2.16% despite the company reporting that its coronavirus vaccine is 90% effective in one of two dosing regimes taken by…
Shares of Alien Metals Ltd (LON: UFO) today fell as much as 19.6% after the company announced that it has raised £2.5 million via a discounted share placement…
Shares of Cineworld Group plc (LON: CINE) today surged 27.6% after the cinema operator got a financial lifeline in the form of a $450 million new debt facility…
Shares of The Western Union Company (NYSE: WU) are likely to open higher tomorrow after the company announced that it has acquired a 15% stake in the digital…
Shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) are set to rally after the FDA granted emergency use authorisation (EUA) for the firm’s COVID-19 treatment, which was given to…
Shares of BioNTech SE (NASDAQ: BNTX) gained nearly 10% Friday on news that a request for Emergency Use Authorization (EUA) will be submitted Pfizer and BioNTech applied for…
Shares of Workday (NASDAQ: WDAY) fell 9.27% after the company issued a warning that the pandemic may continue to impact its revenue growth. The company reported Q3 revenue…
Shares of oil company FTS International (NYSEAMERICAN: FTSE) have rallied on Friday after the company said it successfully completed its financial restructuring and has emerged from Chapter 11…
Shares of Precision BioSciences (NASDAQ: DTIL) are moving higher premarket on Friday after the company announced a research collaboration and exclusive license agreement with Eli Lilly (NYSE: LLY). …
Shares of cyber-security company FireEye Inc (NASDAQ: FEYE) are up nearly 15% premarket on Friday after the company said it will receive $400 million worth of by Blackstone…
US-listed shares of pharmaceutical company Mesoblast (NASDAQ: MESO) are rallying premarket after the company announced an agreement with Novartis (NYSE: NVS) for the development, manufacture and commercialisation of…
Shares of Costain Group PLC (LON: COST) today surged 8.17% after the British technology-based construction and engineering company announced the appointment of Helen Willis as its new Chief…
Shares of Helios Towers PLC (LON: HTWS) fell more than 12% on Friday on news that Millicom subsidiary sold a part of its stake in the company. Citigroup…
Shares of Sage Group PLC (LON: SGE) fell more than 13% on Friday after warning that high cloud investments are likely to drag on the company’s profit margins.…
Shares of Coty (NYSE: COTY) closed 18% higher yesterday to extend its impressive bullish run and total monthly gains to over 115%. Coty share price initially lost about…
Shares of ImmuPharma PLC (LON: IMM) today surged 18.2% after the company reported that its US partner Avion Pharmaceuticals had received a confirmation from the US Food &…
Shares of Genedrive PLC (LON: GDR) today surged 14.5% after data from a study of its Hepatitis-C (HCV) testing kit showed that the kit was able to identify…
Shares of pharmaceutical company Corcept Therapeutics (NASDAQ: CORT) are rallying premarket on Thursday after the company won a Patent Trial and Appeal Board (PTAB) ruling. The ruling was…
Sign up to our free Morning Markets email, every weekday before the open.
Español
Melayu
Deutsch
